ViewRay Receivables

ViewRay (VRAY) currently reports a receivables of $48M as of March 2023. That compares with $28M in the prior-year period — up 69.7% year over year. Use the charts on this page to explore ViewRay's receivables history and peer comparisons.

ViewRay's receivables increased from $28M to $48M — a 69.7% year-over-year increase (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ViewRay reported $48M in receivables as of March 2023. That compares with $28M in the prior-year period — up 69.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $48M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ViewRay, and consider following VRAY for alerts when major investors trade the stock.

ViewRay is classified in the Healthcare sector. On receivables, it currently shows $48M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VRAY with unrelated industries.